Sic semper tyrannis
Thus always to tyrants
Cost Estimate Clarity Act
No Bias in the Baseline Act
287(g) Cooperation Act of 2026
The bill ties federal community‑policing grant eligibility to documented cooperation with federal immigration enforcement and creates verification and an immediate FY2027 effective date—strengthening federal oversight and certainty for cooperating agencies but risking reduced resources, coercive pressure on jurisdictions, and disadvantages for smaller or resource‑strained communities.
Protecting Access to American Products Act
The bill eases short‑term supply disruptions by allowing temporary use of non‑coastwise vessels with predictable approval timelines, but does so at the cost of potential harm to the U.S. maritime industry, maritime readiness, and added administrative strain.
Bankruptcy Threshold Adjustment Act of 2026
The bill expands access to streamlined bankruptcy reorganizations for more small businesses and middle-class debtors—likely preserving jobs and rescues—while raising creditor recovery uncertainty and increasing procedural burdens and transitional fairness challenges for courts and ongoing cases.
No Tax on Takings Act
The bill gives targeted tax relief and flexibility to owners of condemned U.S. property by excluding condemnation gains (with an opt‑out to keep §1033 treatment), but does so at the cost of lower federal revenue and added compliance risk that could cause some taxpayers to lose familiar deferral mechanics.
Protecting Ballot Measures From Foreign Influence Act of 2025
The bill strengthens protections against foreign influence in ballot measures and clarifies funding rules, but it raises compliance costs, risks chilling lawful noncitizen participation, and could trigger enforcement disputes if language is ambiguous.
Sunshine for Regulatory Decrees and Settlements Act of 2025
The bill increases transparency, public participation, and state/local ability to influence agency settlements and clarifies some legal definitions — but it substantially raises procedural hurdles, delays, and costs for agencies and litigants and may reduce incentives and avenues for private enforcement and third‑party challenges.
Skinny Labels, Big Savings Act
The bill expands patient access to lower‑cost generics and reduces legal uncertainty for manufacturers by carving out certain method‑of‑use liability, but it weakens some patent enforcement rights and creates compliance and retroactive legal uncertainties that could reduce R&D incentives.
